医学
胰腺癌
形状记忆合金*
旁侵犯
肠系膜上动脉
阶段(地层学)
新辅助治疗
切除缘
放射科
外科
癌症
内科学
切除术
古生物学
数学
组合数学
生物
乳腺癌
作者
Louisa Bolm,Nisanard Pisuchpen,Motaz Qadan,Avinash Kambadakone,Stefan Sondermann,Katharina Mueller,Natalie Petruch,Kenneth F. May,Piotr Zelga,Martina Nebbia,Theodoros Michelakos,Taisuke Baba,Jorge Roldán,Judy A. Harrison,Kim C. Honselmann,Tobias Keck,Keith D. Lillemoe,Cristina R. Ferrone,Ulrich F. Wellner,Carlos Fernández–del Castillo
出处
期刊:Annals of Surgery
[Lippincott Williams & Wilkins]
日期:2022-03-09
卷期号:276 (2): 215-221
被引量:5
标识
DOI:10.1097/sla.0000000000005433
摘要
Predicting R status before surgery for pancreatic cancer (PDAC) patients with upfront surgery and neoadjuvant therapy.Negative surgical margins (R0) are a key predictor of long-term outcomes in PDAC.Patients undergoing pancreatic resection with curative intent for PDAC were identified. Using the CT scans from the time of diagnosis, the 2019 NCCN borderline resectability criteria were compared to novel criteria: presence of any alteration of the superior mesenteric-portal vein (SMPV) and perivascular stranding of the superior mesenteric artery (SMA). Accuracy of predicting R status was evaluated for both criteria. Patient baseline characteristics, surgical, histopathological parameters, and long-term overall survival (OS) after resection were evaluated.A total of 593 patients undergoing pancreatic resections for PDAC between 2010 and 2018 were identified. Three hundred and twenty-five (54.8%) patients underwent upfront surgery, whereas 268 (45.2%) received neoadjuvant therapy. In upfront resected patients, positive SMA stranding was associated with 56% margin positive resection rates, whereas positive SMA stranding and SMPV alterations together showed a margin positive resection rate of 75%. In contrast to these criteria, the 2019 NCCN borderline criteria failed to predict margin status. In patients undergoing neoadjuvant therapy, only perivascular SMA stranding remained a predictor of margin positive resection, leading to a rate of 33% R+ resections. Perivascular SMA stranding was related to higher clinical T stage (P = 0.003) and clinical N stage (P = 0.043) as well as perineural invasion (P = 0.022). SMA stranding was associated with worse survival in both patients undergoing upfront surgery (36 vs 22 months, P = 0.002) and neoadjuvant therapy (47 vs 34 months, P = 0.050).The novel criteria were accurate predictors of R status in PDAC patients undergoing upfront resection. After neoadjuvant treatment, likelihood of positive resection margins is approximately halved, and only perivascular SMA stranding remained a predictive factor.
科研通智能强力驱动
Strongly Powered by AbleSci AI